The current valuation score of Oragenics Inc is 8.53, ranking 122 out of 388 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.41, which is -90.58% below the recent high of -0.04 and -1096.19% above the recent low of -4.93.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.